vs
阿普塔集团（ATR）与COMSTOCK RESOURCES INC（CRK）财务数据对比。点击上方公司名可切换其他公司
阿普塔集团的季度营收约是COMSTOCK RESOURCES INC的1.2倍（$962.7M vs $787.3M），COMSTOCK RESOURCES INC净利率更高（35.7% vs 7.7%，领先28.0%），COMSTOCK RESOURCES INC同比增速更快（114.3% vs 13.5%），阿普塔集团自由现金流更多（$96.9M vs $-141.2M），过去两年COMSTOCK RESOURCES INC的营收复合增速更高（53.1% vs 2.6%）
阿普塔集团（AptarGroup, Inc.）是总部位于美国的全球性制造企业，主营消费品分配包装产品及药物给药装置的研发与生产，目前在全球18个国家设有生产运营基地，服务医药、快消等多领域客户。
Comstock Resources Inc.是一家独立能源企业，主要从事天然气、原油及天然气凝液的勘探、开发、生产与销售业务，核心运营资产位于美国得州和路易斯安那州的页岩产区，服务北美能源市场。
ATR vs CRK — 直观对比
营收规模更大
ATR
是对方的1.2倍
$787.3M
营收增速更快
CRK
高出100.8%
13.5%
净利率更高
CRK
高出28.0%
7.7%
自由现金流更多
ATR
多$238.1M
$-141.2M
两年增速更快
CRK
近两年复合增速
2.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $962.7M | $787.3M |
| 净利润 | $74.3M | $280.9M |
| 毛利率 | — | — |
| 营业利润率 | 11.0% | 48.3% |
| 净利率 | 7.7% | 35.7% |
| 营收同比 | 13.5% | 114.3% |
| 净利润同比 | -26.4% | 583.3% |
| 每股收益（稀释后） | $1.13 | $0.99 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ATRCRK
| Q4 25 | $962.7M | $787.3M | ||
| Q3 25 | $961.1M | $449.9M | ||
| Q2 25 | $966.0M | $470.3M | ||
| Q1 25 | $887.3M | $512.9M | ||
| Q4 24 | $848.1M | $367.4M | ||
| Q3 24 | $909.3M | $304.5M | ||
| Q2 24 | $910.1M | $246.8M | ||
| Q1 24 | $915.4M | $335.8M |
净利润ATRCRK
| Q4 25 | $74.3M | $280.9M | ||
| Q3 25 | $127.9M | $111.1M | ||
| Q2 25 | $111.7M | $124.8M | ||
| Q1 25 | $78.8M | $-121.3M | ||
| Q4 24 | $100.9M | $-58.1M | ||
| Q3 24 | $100.0M | $-28.9M | ||
| Q2 24 | $90.5M | $-126.3M | ||
| Q1 24 | $83.1M | $-16.3M |
营业利润率ATRCRK
| Q4 25 | 11.0% | 48.3% | ||
| Q3 25 | 14.2% | 11.2% | ||
| Q2 25 | 14.9% | 19.0% | ||
| Q1 25 | 12.8% | 24.6% | ||
| Q4 24 | 14.2% | -0.5% | ||
| Q3 24 | 15.2% | -20.1% | ||
| Q2 24 | 13.8% | -37.5% | ||
| Q1 24 | 12.2% | -3.8% |
净利率ATRCRK
| Q4 25 | 7.7% | 35.7% | ||
| Q3 25 | 13.3% | 24.7% | ||
| Q2 25 | 11.6% | 26.5% | ||
| Q1 25 | 8.9% | -23.6% | ||
| Q4 24 | 11.9% | -15.8% | ||
| Q3 24 | 11.0% | -9.5% | ||
| Q2 24 | 9.9% | -51.2% | ||
| Q1 24 | 9.1% | -4.9% |
每股收益（稀释后）ATRCRK
| Q4 25 | $1.13 | $0.99 | ||
| Q3 25 | $1.92 | $0.40 | ||
| Q2 25 | $1.67 | $0.44 | ||
| Q1 25 | $1.17 | $-0.40 | ||
| Q4 24 | $1.48 | $-0.19 | ||
| Q3 24 | $1.48 | $-0.09 | ||
| Q2 24 | $1.34 | $-0.43 | ||
| Q1 24 | $1.23 | $-0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $409.5M | $23.9M |
| 总债务越低越好 | $1.1B | — |
| 股东权益账面价值 | $2.7B | $2.6B |
| 总资产 | $5.3B | $7.0B |
| 负债/权益比越低杠杆越低 | 0.43× | — |
8季度趋势，按日历期对齐
现金及短期投资ATRCRK
| Q4 25 | $409.5M | $23.9M | ||
| Q3 25 | $264.8M | $19.2M | ||
| Q2 25 | $169.8M | $25.9M | ||
| Q1 25 | $136.8M | $32.9M | ||
| Q4 24 | $226.2M | $6.8M | ||
| Q3 24 | $327.9M | $13.8M | ||
| Q2 24 | $223.9M | $19.3M | ||
| Q1 24 | $201.1M | $6.4M |
总债务ATRCRK
| Q4 25 | $1.1B | — | ||
| Q3 25 | $546.0M | — | ||
| Q2 25 | $535.1M | — | ||
| Q1 25 | $561.2M | — | ||
| Q4 24 | $688.1M | — | ||
| Q3 24 | $822.7M | — | ||
| Q2 24 | $681.5M | — | ||
| Q1 24 | $680.4M | — |
股东权益ATRCRK
| Q4 25 | $2.7B | $2.6B | ||
| Q3 25 | $2.8B | $2.4B | ||
| Q2 25 | $2.7B | $2.2B | ||
| Q1 25 | $2.5B | $2.1B | ||
| Q4 24 | $2.5B | $2.2B | ||
| Q3 24 | $2.5B | $2.3B | ||
| Q2 24 | $2.4B | $2.3B | ||
| Q1 24 | $2.3B | $2.4B |
总资产ATRCRK
| Q4 25 | $5.3B | $7.0B | ||
| Q3 25 | $5.1B | $6.8B | ||
| Q2 25 | $4.9B | $6.7B | ||
| Q1 25 | $4.5B | $6.6B | ||
| Q4 24 | $4.4B | $6.4B | ||
| Q3 24 | $4.6B | $6.3B | ||
| Q2 24 | $4.5B | $6.3B | ||
| Q1 24 | $4.4B | $6.3B |
负债/权益比ATRCRK
| Q4 25 | 0.43× | — | ||
| Q3 25 | 0.20× | — | ||
| Q2 25 | 0.20× | — | ||
| Q1 25 | 0.22× | — | ||
| Q4 24 | 0.28× | — | ||
| Q3 24 | 0.32× | — | ||
| Q2 24 | 0.28× | — | ||
| Q1 24 | 0.29× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $183.7M | $224.2M |
| 自由现金流经营现金流 - 资本支出 | $96.9M | $-141.2M |
| 自由现金流率自由现金流/营收 | 10.1% | -17.9% |
| 资本支出强度资本支出/营收 | 9.0% | 46.4% |
| 现金转化率经营现金流/净利润 | 2.47× | 0.80× |
| 过去12个月自由现金流最近4个季度 | $299.6M | $-449.7M |
8季度趋势，按日历期对齐
经营现金流ATRCRK
| Q4 25 | $183.7M | $224.2M | ||
| Q3 25 | $177.6M | $153.1M | ||
| Q2 25 | $126.0M | $347.6M | ||
| Q1 25 | $82.7M | $174.7M | ||
| Q4 24 | $178.2M | $267.1M | ||
| Q3 24 | $229.3M | $98.2M | ||
| Q2 24 | $143.6M | $83.6M | ||
| Q1 24 | $92.3M | $171.5M |
自由现金流ATRCRK
| Q4 25 | $96.9M | $-141.2M | ||
| Q3 25 | $114.3M | $-188.4M | ||
| Q2 25 | $62.5M | $3.2M | ||
| Q1 25 | $25.9M | $-123.2M | ||
| Q4 24 | $112.2M | $-12.9M | ||
| Q3 24 | $162.7M | $-131.1M | ||
| Q2 24 | $75.4M | $-153.2M | ||
| Q1 24 | $16.7M | $-179.9M |
自由现金流率ATRCRK
| Q4 25 | 10.1% | -17.9% | ||
| Q3 25 | 11.9% | -41.9% | ||
| Q2 25 | 6.5% | 0.7% | ||
| Q1 25 | 2.9% | -24.0% | ||
| Q4 24 | 13.2% | -3.5% | ||
| Q3 24 | 17.9% | -43.1% | ||
| Q2 24 | 8.3% | -62.1% | ||
| Q1 24 | 1.8% | -53.6% |
资本支出强度ATRCRK
| Q4 25 | 9.0% | 46.4% | ||
| Q3 25 | 6.6% | 75.9% | ||
| Q2 25 | 6.6% | 73.2% | ||
| Q1 25 | 6.4% | 58.1% | ||
| Q4 24 | 7.8% | 76.2% | ||
| Q3 24 | 7.3% | 75.3% | ||
| Q2 24 | 7.5% | 95.9% | ||
| Q1 24 | 8.3% | 104.7% |
现金转化率ATRCRK
| Q4 25 | 2.47× | 0.80× | ||
| Q3 25 | 1.39× | 1.38× | ||
| Q2 25 | 1.13× | 2.78× | ||
| Q1 25 | 1.05× | — | ||
| Q4 24 | 1.77× | — | ||
| Q3 24 | 2.29× | — | ||
| Q2 24 | 1.59× | — | ||
| Q1 24 | 1.11× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ATR
| Pharma Segment | $833.1M | 87% |
| Other | $129.6M | 13% |
CRK
| Other | $420.7M | 53% |
| Natural Gas And Oil Sales | $366.6M | 47% |
